Biodesix Profit Margin

Biodesix (BDSX) currently reports a profit margin of -26.97% as of June 2026. That compares with -53.66% in the prior-year period — up 49.7% year over year. That is below the Healthcare sector average of 21.34%. Use the charts on this page to explore Biodesix's profit margin history and peer comparisons.

Biodesix's profit margin increased from -53.66% to -26.97% — a 49.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biodesix's profit margin of -26.97% is lower than the Healthcare sector average of 21.34%. That is roughly 226.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Biodesix's current -26.97% should be judged against Healthcare norms (sector average: 21.34%) and against BDSX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -26.97%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for Biodesix, and consider following BDSX for alerts when major investors trade the stock.